Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 927Neoplasms 609Breast Neoplasms 606Colorectal Neoplasms 457Neoplasm Metastasis 395Ovarian Neoplasms 327Prostatic Neoplasms 314Melanoma 311Lung Neoplasms 295Multiple Myeloma 290Recurrence 278Squamous Cell Carcinoma of Head and Neck 246Stomach Neoplasms 229Pancreatic Neoplasms 227Leukemia, Myeloid, Acute 221Triple Negative Breast Neoplasms 190Endometrial Neoplasms 190Carcinoma, Renal Cell 181Lymphoma, Non-Hodgkin 179Carcinoma, Hepatocellular 179Small Cell Lung Carcinoma 165Leukemia, Lymphocytic, Chronic, B-Cell 156Advanced Solid Tumors 155Lymphoma, Follicular 149Urinary Bladder Neoplasms 139Lymphoma, Large B-Cell, Diffuse 138Lymphoma 137Advanced Solid Tumor 137Uterine Cervical Neoplasms 134Head and Neck Neoplasms 134

Interventions

Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Amyotrophic Lateral Sclerosis × 1 year × Clear all
NCT07002034 2026-06-03

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Reunion Neuroscience Inc

Phase 2 Recruiting
100 enrolled

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡